Showing results (111-120 of 121) with videos related to
Sort By:
Pageof 13
Redox Biology|October 4, 2016
The redox mechanism for vascular barrier dysfunction associated with metabolic disorders: Glutathionylation of Rac1 in endothelial cellsJingyan Han, Robert M Weisbrod, Di Shao, et al.Cancer Science|November 20, 2019
Prevalence of hereditary breast and ovarian cancer (HBOC) predisposition gene mutations among 882 HBOC high-risk Chinese individualsDi Shao, Shaomin Cheng, Fengming Guo, et al.Journal of Ovarian Research|March 16, 2023
Homologous recombination deficiency status predicts response to platinum-based chemotherapy in Chinese patients with high-grade serous ovarian carcinomaZheng Feng, Di Shao, Yuhang Cai, et al.Nature Communications|October 15, 2024
Nivolumab plus anlotinib hydrochloride in advanced gastric adenocarcinoma and esophageal squamous cell carcinoma: the phase II OASIS trialJing Wu, Shilong Zhang, Shan Yu, et al.Scientific Reports|March 4, 2016
A targeted next-generation sequencing method for identifying clinically relevant mutation profiles in lung adenocarcinomaDi Shao, Yongping Lin, Jilong Liu, et al.Cell Death & Disease|December 21, 2022
Targeting SPHK1/S1PR3-regulated S-1-P metabolic disorder triggers autophagic cell death in pulmonary lymphangiomyomatosis (LAM)Fei Li, Yifan Zhang, Zhoujun Lin, et al.Plos One|December 8, 2015
Overexpression of Catalase Diminishes Oxidative Cysteine Modifications of Cardiac ProteinsChunxiang Yao, Jessica B Behring, Di Shao, et al.Genes, Chromosomes & Cancer|December 27, 2017
Development and clinical validation of a circulating tumor DNA test for the identification of clinically actionable mutations in nonsmall cell lung cancerLiping Liu, Han Liu, Di Shao, et al.Journal of Thoracic Disease|May 22, 2018
Comprehensive targeted super-deep next generation sequencing enhances differential diagnosis of solitary pulmonary nodulesMingzhi Ye, Shiyong Li, Weizhe Huang, et al.International Journal of Cancer|February 21, 2022
Neoadjuvant camrelizumab plus chemotherapy for resectable, locally advanced esophageal squamous cell carcinoma (NIC-ESCC2019): A multicenter, phase 2 studyJun Liu, Jingpei Li, Wanli Lin, et al.Pageof 13